808 related articles for article (PubMed ID: 32508825)
1. Dendritic Cells and Their Role in Immunotherapy.
Gardner A; de Mingo Pulido Á; Ruffell B
Front Immunol; 2020; 11():924. PubMed ID: 32508825
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies.
Yang J; Shangguan J; Eresen A; Li Y; Wang J; Zhang Z
Pathol Res Pract; 2019 Dec; 215(12):152691. PubMed ID: 31676092
[TBL] [Abstract][Full Text] [Related]
3. Dendritic Cell-Based Immunotherapy in Lung Cancer.
Stevens D; Ingels J; Van Lint S; Vandekerckhove B; Vermaelen K
Front Immunol; 2020; 11():620374. PubMed ID: 33679709
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment-related dendritic cell deficiency: a target to enhance tumor immunotherapy.
Zhu S; Yang N; Wu J; Wang X; Wang W; Liu YJ; Chen J
Pharmacol Res; 2020 Sep; 159():104980. PubMed ID: 32504832
[TBL] [Abstract][Full Text] [Related]
5. Cellular immunotherapy in multiple myeloma.
Vo MC; Lakshmi TJ; Jung SH; Cho D; Park HS; Chu TH; Lee HJ; Kim HJ; Kim SK; Lee JJ
Korean J Intern Med; 2019 Sep; 34(5):954-965. PubMed ID: 30754964
[TBL] [Abstract][Full Text] [Related]
6. Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade.
Hübbe ML; Jæhger DE; Andresen TL; Andersen MH
Front Immunol; 2020; 11():578349. PubMed ID: 33101304
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy.
Yu WD; Sun G; Li J; Xu J; Wang X
Cancer Lett; 2019 Jun; 452():66-70. PubMed ID: 30902563
[TBL] [Abstract][Full Text] [Related]
8. [Cancer immunotherapy].
Kjeldsen JW; Donia M; Svane IM
Ugeskr Laeger; 2018 May; 180(21):. PubMed ID: 29804567
[TBL] [Abstract][Full Text] [Related]
9. Cell Fate Reprogramming in the Era of Cancer Immunotherapy.
Zimmermannova O; Caiado I; Ferreira AG; Pereira CF
Front Immunol; 2021; 12():714822. PubMed ID: 34367185
[TBL] [Abstract][Full Text] [Related]
10. Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy.
Bracci L; Fragale A; Gabriele L; Moschella F
Front Immunol; 2020; 11():582744. PubMed ID: 33193392
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
Yang P; Meng M; Zhou Q
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
[TBL] [Abstract][Full Text] [Related]
12. Dendritic-cell-based therapeutic cancer vaccines.
Palucka K; Banchereau J
Immunity; 2013 Jul; 39(1):38-48. PubMed ID: 23890062
[TBL] [Abstract][Full Text] [Related]
13. Talkin' Toxins: From Coley's to Modern Cancer Immunotherapy.
Carlson RD; Flickinger JC; Snook AE
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32283684
[TBL] [Abstract][Full Text] [Related]
14. Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy.
Chen S; Lai SWT; Brown CE; Feng M
Front Immunol; 2021; 12():635173. PubMed ID: 33790906
[TBL] [Abstract][Full Text] [Related]
15. ILT4 functions as a potential checkpoint molecule for tumor immunotherapy.
Gao A; Sun Y; Peng G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):278-285. PubMed ID: 29649510
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological combination of nivolumab with dendritic cell vaccines in cancer immunotherapy: An overview.
Calmeiro J; Carrascal MA; Tavares AR; Ferreira DA; Gomes C; Cruz MT; Falcão A; Neves BM
Pharmacol Res; 2021 Feb; 164():105309. PubMed ID: 33212291
[TBL] [Abstract][Full Text] [Related]
17. Harnessing immune checkpoints in myeloid lineage cells for cancer immunotherapy.
Park SY; Kim IS
Cancer Lett; 2019 Jun; 452():51-58. PubMed ID: 30910590
[TBL] [Abstract][Full Text] [Related]
18. Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect.
Nava S; Lisini D; Frigerio S; Bersano A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830221
[TBL] [Abstract][Full Text] [Related]
19. Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.
Shi T; Song X; Wang Y; Liu F; Wei J
Front Immunol; 2020; 11():683. PubMed ID: 32411132
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis.
Saadeldin MK; Abdel-Aziz AK; Abdellatif A
Med Hypotheses; 2021 Jan; 146():110365. PubMed ID: 33221134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
